Menlo Park-based MyOme, a clinical whole genome analysis company helping families understand their risk for diseases, has announced the expansion of its rare disease test to include tandem repeat ...

With choice comes challenges. Choosing embryos with “better” traits carries echoes of a dark past and leaves us facing tough ...

Lenovo today shared updates on the 4th generation of its Genomics Optimization and Scalability Tool - GOAST v4.0. Since its ...

The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.